Format

Send to

Choose Destination
PLoS One. 2015 Aug 27;10(8):e0135708. doi: 10.1371/journal.pone.0135708. eCollection 2015.

The Impact of Goal Disturbance after Cancer on Cortisol Levels over Time and the Moderating Role of COMT.

Author information

1
Department of Health Psychology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
2
Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
3
Department of Medical Psychology, University of Amsterdam, Academic Medical Center Amsterdam, Amsterdam, The Netherlands.

Abstract

Due to physical hindrance and time spent in hospital, a cancer diagnosis can lead to disturbance of personally important goals. Goal disturbance in cancer patients has been related to poorer psychological well-being. However, the relation with physiological measures is yet unknown. The purpose of the current study is to examine the impact of goal disturbance on cortisol as a measure of response to stress over time, and a possibly moderating role of a DNA genotype associated with HPA-axis functioning, Catechol-O-Methyl transferase (COMT). We examined the predictive value of goal disturbance on Cortisol Awakening Response (CAR) and Diurnal Cortisol Slope (DCS) over two periods: 1-7 and 7-18 months post-diagnosis, and the moderating role of COMT during these periods. Hierarchical regression analyses showed that goal disturbance 7 months post-diagnosis significantly predicted a steeper CAR a year later. During that period, the slow COMT variant moderated the relation, in that patients reporting high goal disturbance and had the Met/Met variant, had a more flattened CAR. No other significant effects were found. As steeper CARs have been related to adverse health outcomes, and COMT genotype may modify this risk, these results indicate that goal disturbance and genotype may be important factors to consider in maintaining better psychological and physical health in the already vulnerable population of cancer patients.

PMID:
26313260
PMCID:
PMC4552095
DOI:
10.1371/journal.pone.0135708
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center